The United States, Pfizer. This is the most powerful pharmaceutical company in the world. When we learned that a team in China had developed external organ cultivation technology, Pfizer's senior executives began to pay attention to it immediately.

Everyone knows that if human organs can be cultivated, then this is definitely a major medical market.

"Is this news true or not?" The senior executive of Pfizer asked the first question. Although the Chinese Academy of Sciences has also confirmed it, they still mentioned that this technology is somewhat "surreal".

Medicine and biotechnology have always been the world leader in the United States. This time, Peking University’s team will surpass them so much, which is very normal for them to suspect.

"It's confirmed, it's true!" said the head of the information department. "Their project is an international cooperation project. Research teams from the island countries, South Korea, France and the Netherlands have visited them. They confirmed that it is true. They also watched the process of organ transplantation with their own eyes."

"Professor Okiji from the island country and expert Park Kyung-soo from South Korea said that this is a new technology they have never seen before. The organs they cultivate are 'physiological activities' in the in vitro cultivation device."

"They also went to check the patient's physiological examination data, which were all true and accurate. It can be basically confirmed that they have achieved initial success in this technology."

After the information department reported, the senior executives were silent for a while, and they were all thinking about the impact of this matter.

"There is no doubt that this technology will change the entire organ treatment and transplant market! Many drugs will no longer be needed." As capitalists, the first thing they focus on is the medical market.

"If we cannot grasp this technology, we will lose a lot of drug market share and the market profits brought by new technologies."

"How can I get this technology?" someone asked.

"This technology currently belongs to the research team and does not belong to any company... The core of our investigation is the character named Du Xingyu, the Chinese genius scientist who cloned the Tyrannosaurus Rex before. He is currently a scholar at Peking University."

"This person must be invited, if he can work for us! We will monopolize the world's organ therapy market!"

...

Not only Pfizer, the United States Johnson & Johnson Group, France's Sanofi-Avante Group, Switzerland's Novartis, Roche and other giants have noticed Du Xingyu. They urgently ruled out that representatives went to China, wanting to buy out Du Xingyu and his external organ cultivation technology.

And those medical institutions, biological research institutions, and universities around the world also sent invitation letters to Du Xingyu, asking him to visit, academic exchanges and so on.

Du Xingyu is completely famous in the biology and medical field!

...

"Du Xingyu, Du Xingyu, this is the first time I have lived for most of my life to meet a student like you." In the laboratory, Su Yutang sighed. He was not blaming Du Xingyu, but with a tone of relief and helplessness.

"In just over a year, your achievements have completely surpassed me. As a teacher, I am also happy for you."

"But I must warn you one thing, never let any overseas company control a technology. Once they get it, we will suffer a loss sooner or later!"

"Teacher, I understand, I am also considering this matter." Du Xingyu said that a statement from the Peking University medical team brought attention to him by the whole world.

Many people want this technology. The conditions they offer can make people have money that they can never spend in their entire lives - of course, this person does not include Du Xingyu.

Du Xingyu remembers that the money he spent on building spacecraft in his main world was the savings of all mankind for thousands of years!

In his eyes, the so-called world rich and multinational companies are nothing more than that.

"Then what are you going to do?" Su Yutang said curiously.

Du Xingyu said: "The deans of the Department of Medicine and several affiliated hospitals of Peking University have contacted me. They want to obtain authorization for this technology for further research."

“My idea is to set up a biotech company and license several biotech I’ve developed to them. And I can also have more resources to do research.”

"Start a company by yourself? That's not bad." Su Yutang said. It's normal for professors and scholars to own their own company.

Su Yutang himself has several companies, and he also serves as a technical consultant to dozens of companies.

Du Xingyu's ideas also satisfy Peking University.

The Department of Medicine and affiliated hospitals are willing to jointly contribute funds to help Du Xingyu set up a company and manage it.

Du Xingyu himself serves as chairman directly, and he has the largest shares and veto power. The company's daily operations and management will be managed by them by them, so Du Xingyu can still conduct research.

At the same time, because Du Xingyu's outstanding performance and major research results are of great significance to human society, Peking University specially approved Du Xingyu to become a professor in the Department of Biology of Peking University.

"Sorry, Mr. Du Xingyu rejected all business cooperation." When facing invitations from national pharmaceutical giants such as the United States, France, and Switzerland, Du Xingyu's assistant directly refused.

"Mr. Du Xingyu really doesn't think about it?" The representatives of these large companies were very puzzled. How could anyone not be moved by the conditions they offered?

Over the years, many experts and professors from China have been attracted by their welfare and serviced by them, but they have traveled thousands of miles to China and have not even seen Du Xingyu!

"Sorry." Du Xingyu's assistant said, "In fact, it's not just business cooperation. Mr. Du Xingyu didn't even go to various awards and lectures. He still has dozens of important domestic and foreign awards, but he hasn't received them."

"It's really strange, how could there be such a person? Then what is the purpose of he researching biotechnology?" These people were puzzled.

...

The efficiency of Peking University’s Medical Department was very fast. After finalizing the cooperation method, Du Xingyu’s biotechnology company, a company called “Xinghe Biotechnology”, was established.

The company's main business scope is research in genetic engineering, cell engineering, microbial engineering, biomedicine and other aspects.

As soon as this company was established, it announced that it would share stem cell induction and cultivation through authorized methods, and in vitro organ cultivation technology with Peking University School of Medicine.

These techniques will be used to study and treat a large number of patients who require organ transplantation.

As soon as the news came out, medical institutions, pharmaceutical companies and hospitals around the world were contacting Peking University Medical Department and Xinghe Biotechnology Company.

Their purpose is simple, to obtain authorization and customize the cultivation of human organs with them.

And the regulatory authorities are also conducting emergency reviews to prove its safety.

...

While the outside world is still discussing external organ cultivation techniques, Du Xingyu has already begun his next research plan.

Now the laboratory is under construction and research companies are available, because of technical authorization and funding.

"Now I have three directions to go." Du Xingyu looked at the branch on the technology simulator and fell into deep thought.

At the beginning, he wanted to build humans into interstellar races. Then he must transform human genes, make humans live longer, be able to withstand various cosmic radiation, survive under harsh conditions, etc.

But in this world, it is still not allowed to transform human genes.

This is not the time to study.

The second is to continue to study biomedicine. Du Xingyu is actually indifferent to this. What makes him feel challenging are genetic defects and cancer, which are terminal diseases that humans have not yet conquered.

Humans have been fighting cancer for a long time, and so far, no way to completely cure cancer.

Du Xingyu's friend, Lu Liang, also chose to freeze himself because he was suffering from cancer and went to find a treatment method ten thousand years later.

Du Xingyu will definitely find a way to overcome cancer in this world, but this direction is not what he wants to study now.

The third direction is Du Xingyu's most optimistic direction - biological computers.

Biocomputers, also known as bionic computers, are mainly protein molecules produced by bioengineering technology, and use them as biochips to replace semiconductor silicon wafers and use organic compounds to store data.

Information propagates in the form of waves. When the wave propagates along the protein molecular chain, it will cause changes in the structure order of single and double bonds in the protein molecular chain.

The computing speed of biological computers is 100,000 times faster than that of today's latest generation of computers. It has strong anti-electromagnetic interference capabilities and can completely eliminate interference between circuits. The energy consumption is only one billionth of that of ordinary computers, and it has huge storage capabilities.

The ultimate goal of biological computers is to create an "artificial brain", that is, to use biological materials to create a computing device to achieve the unity of the human brain and computer.

Du Xingyu's teacher in the world, Liu Yuan, once sighed before his death that with the growth of information in human society, humans need to learn more and more things.

Only when a person learns from elementary school to old age can he become an expert in a subdivided field. When he really wants to continue to make breakthroughs, his brain has begun to become dull and his life span cannot continue to support him.

If humans own biological computers, they are not just used to replace working computers, but they actually have an "extra artificial brain" in their brains.

Whether it is storing knowledge or transferring information, it will be greatly improved!

The biochips required by biological computers can also detect the human body's health status in real time just like computers detect hardware performance, which will also have qualitative changes in overcoming diseases!

"I decided that the next research direction is biological computers and artificial brains!" Du Xingyu established a new research direction on the technology simulator.

Like conventional computers, if they want to complete the process, the most important thing is protein chips.
Chapter completed!